BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 17406026)

  • 1. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins.
    Chaturvedi P; Singh AP; Moniaux N; Senapati S; Chakraborty S; Meza JL; Batra SK
    Mol Cancer Res; 2007 Apr; 5(4):309-20. PubMed ID: 17406026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MUC4 expression is regulated by cystic fibrosis transmembrane conductance regulator in pancreatic adenocarcinoma cells via transcriptional and post-translational mechanisms.
    Singh AP; Chauhan SC; Andrianifahanana M; Moniaux N; Meza JL; Copin MC; van Seuningen I; Hollingsworth MA; Aubert JP; Batra SK
    Oncogene; 2007 Jan; 26(1):30-41. PubMed ID: 16799633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance.
    Andrianifahanana M; Moniaux N; Schmied BM; Ringel J; Friess H; Hollingsworth MA; Büchler MW; Aubert JP; Batra SK
    Clin Cancer Res; 2001 Dec; 7(12):4033-40. PubMed ID: 11751498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN-gamma-induced expression of MUC4 in pancreatic cancer cells is mediated by STAT-1 upregulation: a novel mechanism for IFN-gamma response.
    Andrianifahanana M; Singh AP; Nemos C; Ponnusamy MP; Moniaux N; Mehta PP; Varshney GC; Batra SK
    Oncogene; 2007 Nov; 26(51):7251-61. PubMed ID: 17525742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription factor AP-2alpha represses both the mucin MUC4 expression and pancreatic cancer cell proliferation.
    Fauquette V; Aubert S; Groux-Degroote S; Hemon B; Porchet N; Van Seuningen I; Pigny P
    Carcinogenesis; 2007 Nov; 28(11):2305-12. PubMed ID: 17621592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for human MUC4 mucin gene, the ErbB2 ligand, as a target of TGF-beta in pancreatic carcinogenesis.
    Jonckheere N; Perrais M; Mariette C; Batra SK; Aubert JP; Pigny P; Van Seuningen I
    Oncogene; 2004 Jul; 23(34):5729-38. PubMed ID: 15184872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MUC4-expressing pancreatic adenocarcinomas show elevated levels of both T1 and T2 cytokines: potential pathobiologic implications.
    Andrianifahanana M; Chauhan SC; Choudhury A; Moniaux N; Brand RE; Sasson AA; Pour PM; Batra SK
    Am J Gastroenterol; 2006 Oct; 101(10):2319-29. PubMed ID: 17032197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Id1/Id3 knockdown inhibits metastatic potential of pancreatic cancer.
    Shuno Y; Tsuno NH; Okaji Y; Tsuchiya T; Sakurai D; Nishikawa T; Yoshikawa N; Sasaki K; Hongo K; Tsurita G; Sunami E; Kitayama J; Tokunaga K; Takahashi K; Nagawa H
    J Surg Res; 2010 Jun; 161(1):76-82. PubMed ID: 19515385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA interference suppression of MUC1 reduces the growth rate and metastatic phenotype of human pancreatic cancer cells.
    Tsutsumida H; Swanson BJ; Singh PK; Caffrey TC; Kitajima S; Goto M; Yonezawa S; Hollingsworth MA
    Clin Cancer Res; 2006 May; 12(10):2976-87. PubMed ID: 16707592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis.
    Fujisawa T; Joshi B; Nakajima A; Puri RK
    Cancer Res; 2009 Nov; 69(22):8678-85. PubMed ID: 19887609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression of extracellular matrix proteins and adhesion molecules in pancreatic carcinoma.
    Linder S; Castaños-Velez E; von Rosen A; Biberfeld P
    Hepatogastroenterology; 2001; 48(41):1321-7. PubMed ID: 11677955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100P promotes pancreatic cancer growth, survival, and invasion.
    Arumugam T; Simeone DM; Van Golen K; Logsdon CD
    Clin Cancer Res; 2005 Aug; 11(15):5356-64. PubMed ID: 16061848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MUC4 expression increases progressively in pancreatic intraepithelial neoplasia.
    Swartz MJ; Batra SK; Varshney GC; Hollingsworth MA; Yeo CJ; Cameron JL; Wilentz RE; Hruban RH; Argani P
    Am J Clin Pathol; 2002 May; 117(5):791-6. PubMed ID: 12090430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of sialomucin complex, a rat homologue of MUC4, inhibits tumor killing by lymphokine-activated killer cells.
    Komatsu M; Yee L; Carraway KL
    Cancer Res; 1999 May; 59(9):2229-36. PubMed ID: 10232613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic regulation of the human mucin gene MUC4 in epithelial cancer cell lines involves both DNA methylation and histone modifications mediated by DNA methyltransferases and histone deacetylases.
    Vincent A; Ducourouble MP; Van Seuningen I
    FASEB J; 2008 Aug; 22(8):3035-45. PubMed ID: 18492726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity.
    Erkan M; Kleeff J; Gorbachevski A; Reiser C; Mitkus T; Esposito I; Giese T; Büchler MW; Giese NA; Friess H
    Gastroenterology; 2007 Apr; 132(4):1447-64. PubMed ID: 17408641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant expression of transmembrane mucins, MUC1 and MUC4, in human prostate carcinomas.
    Singh AP; Chauhan SC; Bafna S; Johansson SL; Smith LM; Moniaux N; Lin MF; Batra SK
    Prostate; 2006 Mar; 66(4):421-9. PubMed ID: 16302265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antagonistic regulation of human MUC4 and ErbB-2 genes by the Ets protein PEA3 in pancreatic cancer cells: implications for the proliferation/differentiation balance in the cells.
    Fauquette V; Perrais M; Cerulis S; Jonckheere N; Ducourouble MP; Aubert JP; Pigny P; Van Seuningen I
    Biochem J; 2005 Feb; 386(Pt 1):35-45. PubMed ID: 15461591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MUC4 expression and its relation to ErbB2 expression, apoptosis, proliferation, differentiation, and tumor stage in non-small cell lung cancer (NSCLC).
    Karg A; Dinç ZA; Başok O; Uçvet A
    Pathol Res Pract; 2006; 202(8):577-83. PubMed ID: 16814944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular consequences of silencing mutant K-ras in pancreatic cancer cells: justification for K-ras-directed therapy.
    Fleming JB; Shen GL; Holloway SE; Davis M; Brekken RA
    Mol Cancer Res; 2005 Jul; 3(7):413-23. PubMed ID: 16046552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.